Announcement on Outline of the 2025 Annual Performance Briefing
Filed with SSE · · 4 pages · Chinese
Summary by 6ix AI
The company addressed various investor questions during the meeting, including future dividend plans and growth drivers. The company also discussed its ongoing acquisitions and integration efforts, as well as its commitment to high dividend payouts.
Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries
Tibet Rhodiola Pharmaceutical Holding Co. on 6ix
Earlier from Tibet Rhodiola Pharmaceutical
- Indicative Announcement on Convening the 2025 Annual General Meeting
- Announcement on Adding Provisional Proposal at 2025 Annual General Meeting
- Announcement on Renewing Engagement of Accounting Firm
- Announcement on Resolutions of the 1st Extraordinary General Meeting in 2026
- Indicative Announcement on Convening the 1st Extraordinary General Meeting in 2026
Later from Tibet Rhodiola Pharmaceutical
- Announcement on Resolutions of the 2025 Annual General Meeting
- Announcement on Extension of Pledge of Shares Held by Shareholders with Over 5% Shares
- Announcement on Resolutions of the 13th Meeting of the 8th Board of Directors
- Announcement on Resolutions of the 1st Meeting of the 9th Board of Directors
- Announcement on Implementation of Dividend Distribution for 2025
Follow Tibet Rhodiola Pharmaceutical into a list and get an email when it puts out news.
Follow Tibet Rhodiola Pharmaceutical